Skip to main content
Signal8

Galitzer Hillel

SEC insider (Form 3/4/5 filer). CIK 0001904740. Chief Operating Officer at Entera Bio Ltd. (ENTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Aug 7, 2026. Located in JERUSALEM.

Companies Galitzer Hillel has filed insider reports for

  • Entera Bio Ltd. (ENTX): Officer, Chief Operating Officer
Galitzer Hillel profile photo

Galitzer Hillel

CIK: 0001904740

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Entera Bio Ltd. logo
ENTX

Entera Bio Ltd.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Entera Bio Ltd. logo
    ENTX

    Entera Bio Ltd.

    Aug 7, 2026
    Award

    Stock Option (right to buy)

    Direct
    200K shares-
  • Entera Bio Ltd. logo
    ENTX

    Entera Bio Ltd.

    May 7, 2026
    Award
    Direct
    73K shares-
  • Entera Bio Ltd. logo
    ENTX

    Entera Bio Ltd.

    Apr 28, 2025
    Award
    Direct
    26.3K shares-

1-3 of 3